Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Pain 1 Osteonecrosis 1 Nasopharyngeal Carcinoma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Hodgkin Disease 1 Exostoses, Multiple Hereditary 1 Deglutition Disorders 1 Colonic Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Iodine-131 11 Thyrotropin Alfa 9 Sorafenib 8 lenvatinib 6 Thyroidectomy 6 vandetanib 5 Sunitinib 5 Saline Solution 5 pazopanib 4 Triiodothyronine 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Vemurafenib 3 Thyroxine 3 Radiotherapy 3 Everolimus 3 Dexmedetomidine 3 Control Groups 3 Cisplatin 3 AZD 6244 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 trametinib 2 tipifarnib 2 romidepsin 2 dabrafenib 2 belinostat 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Immunohistochemistry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thyroid Neoplasms × Range of Motion, Articular × Clear all

NCT07623005 2026-06-03

PMRT-ThyCa

University of Faisalabad

Phase NA Completed

Pain, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡